A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Middle-aged folks and seniors whose weed use lands them in the hospital are at higher risk for developing dementia within a ...

At her mother’s home in Illinois, Tracy Balhan flips through photos of her dad, Bill Speer. In one picture, he’s smiling in ...

Professor will ‘co-design and test a culturally relevant intervention to meet these unique needs’ of LGBT caregivers.

Advocates will rally in Carson City, Nevada on Wednesday for greater support for dementia patients and their families. More ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

Memory loss is a potential sign of dementia that occurs in progressive stages. Learn about treating and preventing dementia ...

Long ER waits in the U.S. are common, especially for older patients. Some wait for many hours or even days before they get a ...